Stifel Downgrades Bio-Techne Corp. (TECH) to Hold

Go back to Stifel Downgrades Bio-Techne Corp. (TECH) to Hold

Bio-Techne Corp. (TECH) PT Lowered to $75 at RBC Capital

February 1, 2024 4:32 PM EST

RBC Capital analyst Conor McNamara lowered the price target on Bio-Techne Corp. (NASDAQ: TECH) to $75.00 (from $85.00) while maintaining a Sector Perform rating.... More

Bio-Techne (TECH) Misses Q2 EPS by 1c

February 1, 2024 6:35 AM EST

Bio-Techne (NASDAQ: TECH) reported Q2 EPS of $0.40, $0.01 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $272.6 million versus the consensus estimate of $277.55 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

... More

Bio-Techne (TECH) Declares $0.08 Quarterly Dividend; 0.5% Yield

February 1, 2024 6:30 AM EST

Bio-Techne (NASDAQ: TECH) declared a quarterly dividend of $0.08 per share, or $0.32 annualized.


The dividend will be payable on February 26, 2024, to stockholders of record on February 12, 2024, with an ex-dividend date of February 9, 2024.


The annual yield on the dividend is 0.5 percent.

... More